8 weeks 5 vials Covers a 4-week 300 mcg phase plus a 4-week 500 mcg phase
Given their non-invasive nature, accessibility, and cost-effectiveness of sublingual formulations, they may represent a promising approach for long-term B12 management, particularly in patients with impaired absorption or in resource-limited settings
This includes: Pernicious anemia Crohns disease or celiac disease Gastric surgery or gastrointestinal disorders For mild deficiency, starting with 1,000 mcg of Vitamin B12 weekly is common
It is not a drug, food additive, cosmetic, or therapeutic substance, and must not be used in humans or animals
Its considered the safest choice for both adults and children, regardless of age, gender, ethnicity, or BMI